In this issue...
Drug safety advice
- Aliskiren: risk of angioedema and renal dysfunction
- ACE inhibitors and angiotensin II receptor antagonists: recommendations on use during breastfeeding
- Non-steroidal anti-inflammatory drugs: reminder on renal failure and impairment
Yellow Card scheme update
- Patient reporting
Hot topics
- Orlistat: key safety information to support pharmacy availability
Stop press
- New advice on oral salicylate gels for those younger than age 16 years
- Fortodol: risk of serious liver damage
Other information from the MHRA
- Patient Information Leaflet of the month: Caverject
- MHRA–NICE London study day for doctors in training
Drug Safety Update: Volume 2 Issue 10, May 2009 
